These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32726914)

  • 21. Dangerous interaction of bitter melon (
    Unsal O; Sütcüoğlu O; Yazıcı O
    J Oncol Pharm Pract; 2022 Mar; 28(2):486-488. PubMed ID: 34569860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of
    Fan M; Kim EK; Choi YJ; Tang Y; Moon SH
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31487939
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxicity and maternal toxicity attributed to exposure to
    Trautenmuller AL; de Almeida Soares J; Behm KC; Guimarães LMM; Xavier-Silva KR; Monteiro de Melo A; Caixeta GAB; Abadia Marciano de Paula J; Luiz Cardoso Bailão EF; Amaral VCS
    J Toxicol Environ Health A; 2023 Jan; 86(1):36-50. PubMed ID: 36529899
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrated Secondary Metabolomic and Antioxidant Ability Analysis Reveals the Accumulation Patterns of Metabolites in
    Zhang Y; Lu P; Jin H; Cui J; Miao C; He L; Yu J; Ding X; Zhang H
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (
    Kandhari K; Paudel S; Raina K; Agarwal C; Kant R; Wempe MF; O'Bryant C; Agarwal R
    J Cancer Prev; 2021 Dec; 26(4):266-276. PubMed ID: 35047453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy.
    Psilopatis I; Vrettou K; Giaginis C; Theocharis S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Update Review on the Anthelmintic Activity of Bitter Gourd,
    Poolperm S; Jiraungkoorskul W
    Pharmacogn Rev; 2017; 11(21):31-34. PubMed ID: 28503051
    [No Abstract]   [Full Text] [Related]  

  • 29. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
    Yang M; Luo Q; Chen X; Chen F
    J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products.
    Hsieh HJ; Lin JA; Chen KT; Cheng KC; Hsieh CW
    J Food Sci; 2021 Jul; 86(7):3109-3121. PubMed ID: 34146408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia).
    Cuong DM; Kwon SJ; Jeon J; Park YJ; Park JS; Park SU
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29466305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized aqueous extraction of saponins from bitter melon for production of a saponin-enriched bitter melon powder.
    Tan SP; Vuong QV; Stathopoulos CE; Parks SE; Roach PD
    J Food Sci; 2014 Jul; 79(7):E1372-81. PubMed ID: 25041538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
    Jayasooriya AP; Sakono M; Yukizaki C; Kawano M; Yamamoto K; Fukuda N
    J Ethnopharmacol; 2000 Sep; 72(1-2):331-6. PubMed ID: 10967491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of
    Richter E; Geetha T; Burnett D; Broderick TL; Babu JR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of bitter melon (Momordica charantia) cultivars grown in Texas and levels of various phytonutrients.
    Perez JL; Jayaprakasha GK; Crosby K; Patil BS
    J Sci Food Agric; 2019 Jan; 99(1):379-390. PubMed ID: 29888551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
    Snee LS; Nerurkar VR; Dooley DA; Efird JT; Shovic AC; Nerurkar PV
    Nutr J; 2011 Jul; 10():78. PubMed ID: 21794176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-genome sequencing provides insights into the genetic diversity and domestication of bitter gourd (
    Cui J; Yang Y; Luo S; Wang L; Huang R; Wen Q; Han X; Miao N; Cheng J; Liu Z; Zhang C; Feng C; Zhu H; Su J; Wan X; Hu F; Niu Y; Zheng X; Yang Y; Shan D; Dong Z; He W; Dhillon NPS; Hu K
    Hortic Res; 2020; 7(1):85. PubMed ID: 32528697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer.
    Feng T; Wan Y; Dai B; Liu Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bitter gourd (Momordica charantia) as a rich source of bioactive components to combat cancer naturally: Are we on the right track to fully unlock its potential as inhibitor of deregulated signaling pathways.
    Farooqi AA; Khalid S; Tahir F; Sabitaliyevich UY; Yaylim I; Attar R; Xu B
    Food Chem Toxicol; 2018 Sep; 119():98-105. PubMed ID: 29753870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.